An observational study in Coronary Artery Aneurysm, sponsored by St Carlos Hospital, Madrid, Spain. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-01-25.
Sponsored by St Carlos Hospital, Madrid, Spain · Observational
International registry gathering patients with angiographically confirmed coronary aneurysm.
INTRODUCTION AND RATIONALE:
Coronary artery aneurysm is defined as coronary dilatation which exceeds the diameter of normal adjacent segments or the diameter of the patient's largest coronary vessel by 1.5 times. Described by Bourgon, it is an uncommon disease which has been diagnosed with increasing frequency since the advent of coronary angiography. The incidence varies from 1.5% to 5% with male dominance and a predilection for the right coronary artery.
Although several causes have been reported, atherosclerosis accounts for 50% of coronary aneurysms in adults. Reported complications include thrombosis and distal embolization, rupture and vasospasm, causing ischemia, heart failure or arrhythmias. The natural history and prognosis remains obscure, since definitive data are scarce. Controversies persist regarding the use of medical management (antithrombotic) or interventional/surgical procedures.
OBJECTIVES.
Taking into account the classical coronary aneurysm definition, the investigators propose:
ANATOMIC OBJECTIVES.
CLINICAL OBJECTIVES.
THERAPEUTIC OBJECTIVES.
DESIGN:
960 studies on the registry are indexed under Aneurysm; 175 are open to participants now.
This study's enrollment of 1,565 is above the median of 151 across 443 observational studies indexed under Aneurysm.
Browse Aneurysm studies →St Carlos Hospital, Madrid, Spain is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients with a coronary aneurysm diagnosis.
Exclusion Criteria:
Any cause death
dicotomic variable (yes/no)
Time frame: 12 months
Cardiology readmission
dicotomic variable (yes/no)
Time frame: 12 months
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
St Carlos Hospital, Madrid, Spain